Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain

• Main Authors: R. Ariza (Author), A. van Walsem (Author), C. Canal (Author), C. Roldán (Author), L. Betegón (Author), I. Oyagüez (Author), K. Janssen (Author)
• Format: Book
• Published: Elsevier, 2014-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To compare the cost of treating rheumatoid arthritis patients that have failed an initial treatment with methotrexate, with subcutaneous aba - tacept versus other first-line biologic disease-modifying antirheumatic drugs. Method: Subcutaneous abatacept was considered comparable to intrave...